chr3-150558461-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_032025.5(EIF2A):āc.172A>Gā(p.Lys58Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000008 in 1,500,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032025.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2A | NM_032025.5 | c.172A>G | p.Lys58Glu | missense_variant, splice_region_variant | 3/14 | ENST00000460851.6 | NP_114414.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2A | ENST00000460851.6 | c.172A>G | p.Lys58Glu | missense_variant, splice_region_variant | 3/14 | 1 | NM_032025.5 | ENSP00000417229 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000168 AC: 2AN: 119028Hom.: 0 AF XY: 0.0000308 AC XY: 2AN XY: 64926
GnomAD4 exome AF: 0.00000816 AC: 11AN: 1347916Hom.: 0 Cov.: 31 AF XY: 0.0000120 AC XY: 8AN XY: 665678
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.172A>G (p.K58E) alteration is located in exon 3 (coding exon 3) of the EIF2A gene. This alteration results from a A to G substitution at nucleotide position 172, causing the lysine (K) at amino acid position 58 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at